Overview

VyroBio, Inc. is a leading biotechnology company focused on the development of innovative therapies for infectious diseases using cutting-edge viral vector technology. The company is dedicated to transforming patient care through its robust pipeline of promising drug candidates.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to VyroBio, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.